Efficacy of Morpholino-modified Antisense Oligomers Directed against Tumor Necrosis Factor-α mRNA
Open Access
- 1 July 1996
- journal article
- research article
- Published by Elsevier
- Vol. 271 (29) , 17445-17452
- https://doi.org/10.1074/jbc.271.29.17445
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- An Assay for Transforming Growth Factor-β Using Cells Transfected with a Plasminogen Activator Inhibitor-1 Promoter-Luciferase ConstructAnalytical Biochemistry, 1994
- Therapeutic Applications of OligonucleotidesAnnual Review of Pharmacology and Toxicology, 1992
- Tumor Necrosis Factor Plays an Essential Role in Determining Hypersensitivity Pneumonitis in a Mouse ModelAmerican Journal of Respiratory Cell and Molecular Biology, 1991
- Tumor Necrosis Factor: Alpha and Beta Subtypes Appear in Circulation during Onset of Sepsis-induced Lung InjuryAmerican Review of Respiratory Disease, 1991
- Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages.The Journal of Experimental Medicine, 1990
- Tumor necrosis factor participates in the pathogenesis of acute immune complex alveolitis in the rat.Journal of Clinical Investigation, 1989
- The Biology of Cachectin/TNF -- A Primary Mediator of the Host ResponseAnnual Review of Immunology, 1989
- Cachetin/TNF-α in Septic Shock and Septic Adult Respiratory Distress SyndromeAmerican Review of Respiratory Disease, 1988
- Neutrophil activation on biological surfaces. Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes.Journal of Clinical Investigation, 1987
- Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus.Proceedings of the National Academy of Sciences, 1987